Antimicrobial peptides-promising alternatives to conventional antibiotics

Journal of Molecular Microbiology and Biotechnology

Volumn 20, Issue 4, 2011, Pages 228-235

  Baltzer, Sylvia A ^a   Brown, Melissa H ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Antibiotics; Antimicrobial resistance; Membrane modification; Peptide structure; Therapeutic agents

Indexed keywords

GRAMICIDIN S; NISIN; PEXIGANAN; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT;

AGRICULTURE; ALPHA HELIX; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL MEMBRANE; BETA SHEET; CELL DEATH; CHANNEL GATING; CROSS RESISTANCE; CYTOTOXICITY; DRUG DEGRADATION; DRUG INDUSTRY; DRUG SENSITIVITY; ESCHERICHIA COLI; HUMAN; HYGIENE PRODUCT; MEMBRANE DAMAGE; MEMBRANE DEPOLARIZATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEISSERIA GONORRHOEAE; PSEUDOMONAS FLUORESCENS; REVIEW; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; VIRUS INFECTION;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; PEPTIDES;

BACTERIA (MICROORGANISMS); FUNGI; MAMMALIA; NEGIBACTERIA; POSIBACTERIA;

EID: 80052336721     PISSN: 14641801     EISSN: 16602412     Source Type: Journal    
DOI: 10.1159/000331009     Document Type: Review

References (60)

1. Aiello AE, Larson E: Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community. Lancet Infect Dis 2003; 3:501-506. (Pubitemid 36919096)
2. Alves ID, Correia I, Jiao CY, Sachon E, Sagan S, Lavielle S, Tollin G, Chassaing G: The interaction of cell-penetrating peptides with lipid model systems and subsequent lipid reorganization: thermodynamic and structural characterization. J Pept Sci 2009; 15: 200-209.
3. Appelt C, Schrey AK, Soderhall JA, Schmieder P: Design of antimicrobial compounds based on peptide structures. Bioorg Med Chem Lett 2007; 17: 2334-2337. (Pubitemid 46484312)
4. Arnold SR: Revenge of the killer microbe. Can Med Assoc J 2007; 177:895-896. (Pubitemid 47612823)
5. Bayer AS, Prasad R, Chandra J, Koul A, Smriti M, Varma A, Skurray RA, Firth N, Brown MH, Koo SP, Yeaman MR: In vitro resistance of Staphylococcus aureus to thrombin-in-duced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect Immun 2000; 68: 3548-3553. (Pubitemid 30340456)
6. Bell G, Gouyon PH: Arming the enemy: the evolution of resistance to self-proteins. Microbiology 2003; 149: 1367-1375. (Pubitemid 36764061)
7. Bradshaw J: Cationic antimicrobial peptides: issues for potential clinical use. BioDrugs 2003; 17:233-240. (Pubitemid 36999949)
8. Brown KL, Hancock RE: Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 2006; 18: 24-30. (Pubitemid 43049644)
9. Brown KL, Mookherjee N, Hancock RE (eds): Antimicrobial, Host Defence Peptides and Proteins. Encyclopedia of Life Sciences. Chichester, Wiley, 2007, pp 1-11.
10. Cherkasov A, Hilpert K, Jenssen H, Fjell CD, Waldbrook M, Mullaly SC, Volkmer R, Hancock REW: Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. Chem Biol 2009; 4:65-74.
11. Delves-Broughton J: Nisin as a food preservative. Food Aust 2005; 57: 525-527. (Pubitemid 41809248)
12. Delves-Broughton J, Blackburn P, Evans RJ, Hu-genholtz J: Applications of the bacteriocin, nisin. Antonie Van Leeuwenhoek 1996; 69: 193-202. (Pubitemid 26058497)
13. Fox JL: The business of developing antibacterial. Nat Biotechnol 2006; 24:1521-1528.
14. Gottler LM, Ramamoorthy A: Structure, membrane orientation, mechanism, and function of pexiganan-a highly potent antimicrobial peptide designed from magainin. Biochim Biophys Acta 2009; 1788:1680-1686.
15. Guina T, Yi EC, Wang HL, Hackett M, Miller SI: A PhoP-regulated outer membrane protease of Salmonella enterica serovar Typhimurium promotes resistance to a-helical antimicrobial peptides. J Bacteriol 2000; 182: 4077-4086. (Pubitemid 30436571)
16. Gunn JS: Bacterial modification of LPS and resistance to antimicrobial peptides. J Endotoxin Res 2001; 7: 57-62. (Pubitemid 32496461)
17. Gunn JS, Lim KB, Krueger J, Kim K, Guo L, Hackett M, Miller SI: PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol 1998; 27:1171-1182. (Pubitemid 28137969)
18. Guo L, Lim KB, Poduje CM, Daniel M, Gunn JS, Hackett M, Miller SI: Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 1998; 95: 189-198. (Pubitemid 28473780)
19. Hancock RE: Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 2001; 1:156-164. (Pubitemid 33586049)
20. Hancock RE: Concerns regarding resistance to self-proteins. Microbiology 2003; 149:3343-3344.
21. Hancock RE, Brown KL, Mookherjee N: Host defence peptides from invertebrates-emerging antimicrobial strategies. Immu-nobiology 2006; 211:315-322.
22. Hancock RE, Diamond G: The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 2000; 8:402-410.
23. Hancock RE, Sahl HG: Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006; 24: 1551-1557. (Pubitemid 44967479)
24. Hawkey PM: The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008; 62(suppl 1):i1-i9.
25. Hawkey PM, Jones AM: The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64(suppl 1):i3-i10.
26. Huang HW: Action of antimicrobial peptides: two-state model. Biochemistry 2000; 39: 8347-8352. (Pubitemid 30489931)
27. Iwasaki T, Saido-Sakanaka H, Asaoka A, Taylor D, Ishibashi J, Yamakawa M: In vitro activity of diasterimeric antimicrobial peptides alone and in combination with antibiotics against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. J Insect Biotechnol Sericol 2007; 76:25-29. (Pubitemid 46464119)
28. Izadpanah A, Gallo RL: Antimicrobial peptides. J Am Acad Dermacol 2005; 52:381-390.
29. Kaufmann BB, Hung DT: The fast track to mul-tidrug resistance. Mol Cell 2010; 37: 297-298.
30. Keymanesh K, Soltani S, Sardari S: Application of antimicrobial peptides in agriculture and food industry. World J Microbiol Biotechnol 2009; 25: 933-944.
31. Kollef MH: Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31:S131-S138. (Pubitemid 32291120)
32. Lata S, Sharma BK, Raghava GP: Analysis and prediction of antibacterial peptides. BMC Bioinf 2007; 8: 263.
33. Levy SB: Multidrug resistance-a sign of the times. N Engl J Med 1998; 338:1376-1378.
34. Livermore DM: Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 2003; 36:S11-S23. (Pubitemid 36140465)
35. Marr AK, Gooderham WJ, Hancock RE: Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 2006; 6:468-472. (Pubitemid 44340665)
36. Matsuzaki K: Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Bio-chim Biophys Acta 1999; 1462:1-10.
37. McEwen SA, Fedorka-Cray PJ: Antimicrobial use and resistance in animals. Clin Infect Dis 2002; 34:S93-S106. (Pubitemid 34553688)
38. Mohan K V, Rao SS, Atreya CD: Antiviral activity of selected ant im icrobia l peptides aga inst v ac-cinia virus. Antiviral Res 2010; 86:306-311.
39. Monroe S, Polk R: Antimicrobial use and bacterial resistance. Curr Opin Microbiol 2000; 3: 496-501.
40. Moore A: The big and small of drug discovery. Biotech versus pharma: advantages and drawbacks in drug development. EMBO Rep 2003; 4:114-117. (Pubitemid 36322149)
41. Moskowitz SM, Ernst RK, Miller SI: PmrAB, a two-component regulatory system of Pseu-domonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J Bac-teriol 2004; 186: 575-579. (Pubitemid 38076447)
42. Nakamura T, Furunaka H, Miyata T, Tokunaga F, Muta T, Iwanaga S, Niwa M, Takao T, Shi-monishi Y: Tachyplesin, a class of antimicrobial peptides from the hemocytes of the horseshoe-crab (Tachypleus tridentatus)-isolation and chemical structure. J Biol Chem 1988; 263: 16709-16713. (Pubitemid 18268849)
43. Perron GG, Zasloff M, Bell G: Experimental evolution of resistance to an antimicrobial peptide. Proc R Soc B 2006; 273: 251-256. (Pubitemid 46768100)
44. Peschel A: How do bacteria resist human antimicrobial peptides? Trends Microbiol 2002; 10: 179-186. (Pubitemid 34242955)
45. Peschel A, Collins LV: Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peptides 2001; 22:16 51-1659. (Pubitemid 32918244)
46. Powers JP, Hancock RE: The relationship between peptide structure and antibacterial activity. Peptides 2003; 24: 1681-1691. (Pubitemid 38198075)
47. Renau TE, Leger R, Flamme EM, Sangalang J, She MW, Yen R, Gannon CL, Griffith D, Chamberland S, Lomovskaya O, Hecker SJ, Lee VJ, Ohta T, Nakayama K: Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J Med Chem 1999; 42: 4928-4931.
48. Roy H, Dare K, Ibba M: Adaptation of the bacterial membrane to changing environments using aminoacylated phospholipids. Mol Microbiol 2009; 71: 547-550.
49. Sahl H, Peschel A: The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 2006; 4: 529-536. (Pubitemid 43905612)
50. Samuelsen O, Haukland HH, Jenssen H, Kramer M, Sandvik K, Ulvatne H, Vorland LH: Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus. FEBS Lett 2005; 579: 3421-3426. (Pubitemid 40800292)
51. Shafer WM, Qu X, Waring AJ, Lehrer RI: Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/divi-sion efflux pump family. Proc Natl Acad Sci USA 1998; 95:1829-1833. (Pubitemid 28103479)
52. Shai Y: Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by a-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1999; 1462:55-70.
53. Shi YX, Cromie MJ, Hsu FF, Turk J, Groisman EA: PhoP-regulated Salmonella resistance to the antimicrobial peptides magainin 2 and poly-my xin B. Mol Microbiol 2004; 53: 229-241. (Pubitemid 38901393)
54. Spratt BG: Antibiotic resistance: counting the cost. Curr Biol 1996; 6:1219-1221. (Pubitemid 27004899)
55. Straus SK, Hancock RE: Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Bio-chim Biophys Acta 2006; 1758:1215-1223. (Pubitemid 44436068)
56. Tanabe K, Lamping E, Adachi K, Takano Y, Ka-wabata K, Shizuri Y, Niimi M, Uehara Y: Inhibition of fungal ABC transporters by un-narmicin A and unnarmicin C, novel cyclic peptides from marine bacterium. Biochem Biophys Res Commun 2007; 364: 990-995. (Pubitemid 350087898)
57. Vizioli J, Salzet M: Antimicrobial peptides versus parasitic infections? Trends Parasitol 2002; 18: 475-476. (Pubitemid 35441255)
58. Yang L, Weiss TM, Lehrer RI, Huang HW: Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys J 2000; 79: 2002-2009.
59. Yount NY, Bayer AS, Xiong YQ, Yeaman MR: Advances in antimicrobial peptide immuno-biolog y. Biopolymers 2006; 84: 435-458.
60. Zasloff M: Antimicrobial peptides of multicel-lular orga nisms. Nature 2002; 415: 389-395. (Pubitemid 34100944)